BIRMINGHAM, Ala. — October 30, 2026 — Rampart, the leader in lead-free enhanced radiation protection, today announced a significant scientific and clinical presence at TCT 2026, taking place October 31–November 3 in San Diego.

Four scientific presentations will examine occupational radiation protection across the interventional environment, with research spanning physicians, interventional echocardiographers, nurses and technologists, as well as multiple procedural types and clinical settings.

The presentations add to a growing body of l evidence from Rampart’s SECURE Clinical Program, the company’s commitment to backing every claim with rigorous data. The program supports total body protection for the entire team, so clinicians can safely shed the lead during procedures. “Radiation safety is undergoing an important transformation, and strong clinical evidence has to be the foundation of that change,” said Robert Foster, MD, Founder and Chief Medical Officer of Rampart. “What is particularly meaningful about the research being presented at TCT is its breadth. We are building evidence across procedures, clinical settings and members of the procedural team. As we work to redefine what radiation protection can and should look like, we remain committed to doing so on a solid foundation of high-level clinical evidence.”

Rampart Scientific Presentations at TCT 2026

Sunday, November 1 | 1:40 p.m. | Station 10
TCT 354: Reduction in Eye Radiation Exposure Using a Novel Head-of-Bed Radiation Shield During Structural Heart Interventions
Ali Ebrahimi, MD

Monday, November 2 | 8:10 a.m.
TCT 589: Observed Reductions in Lead-Free Radiation Exposure with the Rampart Guardian System during Cardiac and Peripheral Vascular Procedures
Matthew Herzig, MD

Monday, November 2 | 2:00–3:00 p.m. | Station 6

TCT 962: Near-Zero Occupational Radiation Exposure Among Nurses and Technologists Across Contemporary Catheterization Laboratory Procedure
Shannon Klump, RN

TCT 963: Occupational Radiation Exposure During Left Heart Catheterization and PCI: Real-World Dosimetry According to Vascular Access using the Rampart Radiation Protection System
Matthew Herzig, MD

Rampart Technology Featured Throughout TCT’s Live Case Program

In addition to its scientific presence, Rampart technology will be used in cases featured throughout TCT 2026 from leading cardiovascular institutions, including Toronto General Hospital, Scripps Clinic, Beth Israel Deaconess Medical Center and New York-Presbyterian/Columbia University Irving Medical Center.

The cases span coronary and structural heart interventions, demonstrating the integration of enhanced radiation protection across a range of complex procedural environments and leading cardiovascular programs.

Together, Rampart’s scientific presentations and presence within the TCT case program reflect the company’s broader commitment to advancing Total Body, Total Team Protection™ and establishing a new standard for occupational radiation safety in the interventional lab.

TCT attendees can experience Rampart’s lead-free enhanced radiation protection solutions at Rampart Booth 4727, with additional systems and content featured throughout the exhibit floor. 

About Rampart

Rampart is a Birmingham, Alabama-based medical device company redefining interventional radiation safety through rigorous clinical evidence. Supported by two randomized controlled trials and peer-reviewed real-world evidence in more than 1,700 procedures across 150+ sites, Rampart’s solutions deliver greater than 99% scatter radiation reduction and are proven to be up to 20x more effective than lead aprons and traditional shields.

Designed with zero pounds of wearable burden and engineered so that it adds no weight to the clinician or the procedure table, Rampart eliminates the orthopedic strain long associated with wearing lead aprons while preserving full procedural freedom. As the sole worldwide manufacturer of ClearShield Technology® — a proprietary lead-free bismuth acrylic that delivers consistent 1mm lead equivalency protection — Rampart is the only ERPD built from completely lead-free materials, supporting a more sustainable approach to radiation safety without compromises of traditional lead-based shielding. Available nationwide and through global distribution partnerships, Rampart provides Total Body, Total Team Protection™ for every member of the interventional team, enabling clinicians everywhere to safely Shed the Lead®.

For more information, visit www.rampart.com.